Trends and Perspective of Advanced Nanotechnology for Bio-Sensing, Imaging and Cancer Therapy
A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensor and Bioelectronic Devices".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 1884
Special Issue Editors
Interests: cancer diagnostic technique; disease diagnostic biosensor; in vivo fluorescence/nuclear magnetic imaging; cancer multifunctional therapy
Special Issues, Collections and Topics in MDPI journals
Interests: microfluidic; lab on a chip; disease diagnostic biosensor; cancer diagnostic technique
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has become a game changer, providing innovative solutions to address the pressing challenges in bio-sensing, imaging, and cancer therapy. Nanotechnology, particularly bio-nanotechnology, employs specific identification, precise labelling, flexible imaging, and effective therapeutic capabilities. They can be combined with physicochemical sensors and micro/nano tools to provide user-friendly diagnostic and medical treatments systems, with an ever-expanding range of applications to improve people’s health, well-being, and the environment. In addition, the development of advanced bio-responsive nanomaterial-based diagnostic/therapeutic probes has enabled precise target bioimaging and smart nano-medicine. Moreover, combination with machine learning and artificial intelligence (AI) has enabled the effective use of bio-nanotechnology for the rapid and accurate diagnosis and effective treatment of malignant tumours, neurodegenerative diseases, and other difficult-to-treat diseases.
This Special Issue invites researchers and practitioners to submit original research papers and review articles on advanced nanotechnology use in biosensing, imaging, and cancer therapy. We look forward to applications, including, but not limited to, smart materials, microfluidic chips, single/dual/multimodality imaging, artificial intelligence (AI), tumor photothermal/photodynamic therapy, tumor gene therapy, tumor immunotherapy, and so on.
Prof. Dr. Xuemei Wang
Dr. Xiaohui Liu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- advanced nanotechnology
- biosensing
- multimodal imaging probes
- dual-modality/multimodality imaging
- artificial intelligence (AI)
- diagnostic/therapeutic probes
- tumor gene/immunotherapy
- microfluidic chip
